List your company

ResearchFormerly WizWand

FH/WT Segmentation

Benchmarks

DatasetSOTA methodMetricTrendResultsLast updated

BraTS Glioma post 2024 (val)

87.6Dice (Lesion-wise)

2

Feb 26, 2026

Glioma post Internal (test)

unified FLAIR hyperintensity segmentation model

84.57Lesion Dice

1

Feb 26, 2026

BraTS Glioma pre 2023 (val)

91Dice (Lesion-wise)

1

Feb 26, 2026

Glioma pre Internal (test)

unified FLAIR hyperintensity segmentation model

90.92Dice (lesion-wise)

1

Feb 26, 2026

BraTS Metastasis 2023 (val)

60.2Dice (Lesion-wise)

1

Feb 26, 2026

Metastasis Internal (test)

unified FLAIR hyperintensity segmentation model

80.08Dice (lesion-wise)

1

Feb 26, 2026

BraTS Meningioma 2023 (val)

85.6Dice (Lesion-wise)

1

Feb 26, 2026

Meningioma Internal (test)

unified FLAIR hyperintensity segmentation model

88.65Lesion-wise Dice

1

Feb 26, 2026